Stryker Management
Management criteria checks 3/4
Stryker's CEO is Kevin Lobo, appointed in Oct 2012, has a tenure of 11.5 years. total yearly compensation is $20.77M, comprised of 6.7% salary and 93.3% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth $32.95M. The average tenure of the management team and the board of directors is 5.6 years and 6.7 years respectively.
Key information
Kevin Lobo
Chief executive officer
US$20.8m
Total compensation
| CEO salary percentage | 6.7% |
| CEO tenure | 11.5yrs |
| CEO ownership | 0.03% |
| Management average tenure | 5.6yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today
Jan 02Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 22Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 08Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
Aug 22Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Jul 18Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price
Jul 06These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well
Jun 17Stryker: Good Prospects
Jun 14With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case
May 24Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?
May 01Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Apr 18Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Apr 06Is Stryker (NYSE:SYK) Using Too Much Debt?
Feb 27Stryker: Typically Excellent, Typically Expensive
Feb 16Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback
Feb 07If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity
Feb 02Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M
Jan 31Stryker initiated at sector weight by KeyBanc on limited upside potential
Jan 25Stryker: Excellent Recent And Continuing Performance
Jan 09Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital
Jan 08At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Dec 26Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Dec 12Stryker lifts dividend by 7.9% to $0.75/share
Dec 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$21m | US$1m | US$3b |
| Sep 30 2023 | n/a | n/a | US$3b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$3b |
| Dec 31 2022 | US$19m | US$1m | US$2b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$16m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$13m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$2b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$15m | US$1m | US$2b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$14m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$14m | US$1m | US$1b |
Compensation vs Market: Kevin's total compensation ($USD20.77M) is above average for companies of similar size in the US market ($USD13.41M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Lobo (58 yo)
11.5yrs
Tenure
US$20,767,847
Compensation
Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.5yrs | US$20.77m | 0.026% $ 32.9m | |
| VP & CFO | 8yrs | US$6.84m | 0.0068% $ 8.5m | |
| Group President of Global Quality & Operations | 6yrs | US$4.47m | 0.0024% $ 3.0m | |
| Group President of MedSurg & Neurotechnology | 5.7yrs | US$6.49m | 0.015% $ 18.8m | |
| Group President of Orthopaedics & Spine | 5.7yrs | US$6.49m | 0.014% $ 17.1m | |
| VP & Chief Accounting Officer | 2.7yrs | no data | 0.00069% $ 859.2k | |
| CTO and VP of Global R&D - Joint Replacement | no data | no data | no data | |
| VP, Chief Information Officer & Chief Information Security Officer | 5.6yrs | no data | no data | |
| Vice President of Finance & Investor Relations | 1.8yrs | no data | no data | |
| VP & Chief Legal Officer | 5yrs | US$2.24m | 0.0025% $ 3.1m | |
| VP & Chief Compliance Officer | no data | no data | no data | |
| VP of Communications | 5.3yrs | no data | 0.0083% $ 10.3m |
5.6yrs
Average Tenure
56yo
Average Age
Experienced Management: SYK's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.5yrs | US$20.77m | 0.026% $ 32.9m | |
| Independent Director | 3.9yrs | US$319.25k | 0.00040% $ 498.1k | |
| Director Emeritus | 5.9yrs | US$38.86k | no data | |
| Chairman Emeritus | no data | US$286.99k | 5.27% $ 6.6b | |
| Independent Director | 40.3yrs | US$322.74k | 4.95% $ 6.2b | |
| Independent Director | 6.7yrs | US$332.59k | 0.0013% $ 1.7m | |
| Independent Director | 14.8yrs | US$319.25k | 0.0084% $ 10.4m | |
| Independent Director | 13.3yrs | US$334.25k | 0.0031% $ 3.8m | |
| Lead Independent Director | 5.9yrs | US$354.16k | 0.00022% $ 273.9k | |
| Independent Director | 5.9yrs | US$319.25k | 0.0012% $ 1.5m | |
| Independent Director | 3.3yrs | US$319.25k | 0.00040% $ 498.1k | |
| Independent Director | 10.4yrs | US$342.74k | 0.0015% $ 1.8m |
6.7yrs
Average Tenure
61.5yo
Average Age
Experienced Board: SYK's board of directors are considered experienced (6.7 years average tenure).